|
CN111032032A
|
|
Tablets of omega-3fatty acid amino acid salts with high active ingredient content
|
|
WO2019008101A1
|
|
Enteric coated solid dosage form comprising omega-3 fatty acid amino acid salts
|
|
ZA201801077B
|
|
Effervescent formulations of ornithine aspartate
|
|
CA3043647A1
|
|
Asymmetrically substituted bis-alkenyl diphenyl ethers, their preparation and use
|
|
WO2017202942A1
|
|
Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
|
|
EP3372670A1
|
|
Culture media comprising n-acyl-x-glutamine dipeptides
|
|
DE102017203908B3
|
|
Culture medium comprising oligopeptides
|
|
EP3372671A1
|
|
Culture medium comprising olgopeptides
|
|
EP3248467A1
|
|
Method for preparing a composition containing omega-3-fatty acid-l-lysin-salts
|
|
EP3167879A1
|
|
Gastric retention active delivery systems
|
|
EP3144289A1
|
|
[(2-ethoxy-5-trans-1-propen-1-yl)-phenoxyl]-terminated compounds
|
|
EP3144290A1
|
|
Alkenylphenoxy-substituted 1,1-diphenylethylenes, processes for their preparation, and their use
|
